Lactulose PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Lactulose PCD pharma franchise company offering 2 syrup formulations. Manufactured at WHO-GMP certified facilities, this range gives franchise partners a well-established osmotic laxative with steady demand across constipation and liver-care prescribing.
What is Lactulose?
Lactulose is a semi-synthetic, non-absorbable disaccharide osmotic laxative. It passes unchanged to the colon, where it draws water into the bowel to soften stool and is fermented by gut bacteria into organic acids. This acidification converts absorbable ammonia into non-absorbable ammonium, which is why lactulose both relieves constipation and lowers blood ammonia in liver disease. Learn more on PubChem.
Therapeutic Applications of Lactulose
Lactulose is used for chronic constipation and for the treatment and prevention of hepatic encephalopathy (portal-systemic encephalopathy) in patients with liver failure. It is prescribed by gastroenterologists, hepatologists, paediatricians and general physicians.
Why Lactulose is a High-Potential Molecule for Distributors
Lactulose is a long-trusted, guideline-backed therapy that combines everyday constipation use with an essential role in hepatic encephalopathy management, where it is often taken lifelong. This mix of high-frequency general demand and dependable chronic liver-care use makes lactulose syrup a reliable, low-risk repeat-purchase molecule for a franchise portfolio.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.
References
- PubChem – Lactulose Compound Summary, U.S. National Library of Medicine
- PubMed – Clinical literature on Lactulose
Our formulations of Lactulose find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: